Terns Pharmaceuticals on the Brink of Innovation With Upcoming TERN-701 Data Release
Top 3 Health Care Stocks You'll Regret Missing In Q4
Press Release: Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Express News | Terns Pharmaceuticals Appoints Heather Turner, J.d., to Board of Directors
The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.
Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.
Eli Lilly, Novo Nordisk Shares Slide as Trump Picks RFK Jr. for HHS Post
We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth
Terns Pharmaceuticals Reports Q3 Progress and Financials
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
Terns Pharma Analyst Ratings
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $26
H.C. Wainwright Maintains Terns Pharmaceuticals(TERN.US) With Hold Rating, Raises Target Price to $7.5
Express News | Terns Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $7.5 From $5.5
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Terns Pharmaceuticals: Promising Oncology Developments and Strategic Pipeline Diversification Justify Buy Rating
Terns Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Terns Pharmaceuticals | 8-K: Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates
Express News | Terns Pharmaceuticals Q3 Net Income USD -21.945 Million Vs. IBES Estimate USD -25.7 Million
Express News | Terns Pharmaceuticals Q3 Basic EPS USD -0.28
Press Release: Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates